EGFR Activation Linked to Enhanced YAP Signaling in Diabetic Retinal Fibrosis Study by Zhang et al

A recent study has identified a connection between the epidermal growth factor receptor (EGFR) and Yes-associated protein (YAP) signaling in the development of diabetic retinal fibrosis. Researchers found that EGFR plays a role in enhancing YAP signaling, which contributes to fibrotic changes in the retina associated with diabetes. The findings highlight a complex interplay between these molecular pathways, shedding light on mechanisms underlying diabetic complications.

The study, conducted by Zhang et al., explored how EGFR influences YAP activity within retinal cells affected by diabetes. Diabetic retinal fibrosis is characterized by excessive tissue scarring in the retina, which can impair vision over time. The researchers discovered that EGFR activation boosts YAP signaling, promoting cellular processes linked to fibrosis. These results provide insight into how molecular interactions drive pathological changes in diabetic retinopathy and may inform future research into therapeutic strategies targeting these pathways.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: November 20, 2025

Related posts:

Elevated Stroke Risk Persists for Over a Decade After Minor Stroke or TIA Researchers Identify Nageotte Nodules as Indicators of Nerve Damage in Diabetic Neuropathy FlyteHealth and Heartbeat Health Partner to Launch Virtual-First Program for Cardiometabolic and Cardiovascular Care University of Maryland Researchers Report Positive Phase I Trial Results for Intranasal H5N1 Vaccine

Author

GOAI